Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 7/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 7/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 7/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | HRH2 | P25021 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 3/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5874316 | 0.95 | GNAI3 (0.50) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5874516 | 0.93 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5875251 | 0.93 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5875013 | 0.93 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5874398 | 0.93 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5874232 | 0.93 | GNAI3 (0.53) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL27513970 | 0.92 | GNAI3 (0.51) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL2486462 | 0.89 | ALDH1A1 (0.41) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL1642959 | 0.89 | GNAI3 (0.38) | GNAI3GNAO1GNAI1SIGMAR1HRH2 | |
| SCHEMBL5875158 | 0.89 | TSHR (0.34) | GNAI3GNAO1GNAI1SIGMAR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116438177-A | Targeted chimeric compounds, pharmaceutical compositions containing same, and preparation methods and uses thereof | 江苏亚虹医药科技股份有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116171272-A | Novel VDAC1 inhibitors | 阿巴尔塞奥制药公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-102741251-A | Fused pyridine derivatives | SHANDONG XUANZHU MEDICINAL CO LTD | 2012-10-17 | — | — | CN | disclosed |
| US-7128976-B2 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2006-10-31 | — | — | US | disclosed |
| US-20030091838-A1 | Composition for film formation, method of film formation, and silica-based film | JSR CORPORATION (JP) | 2003-05-15 | — | — | US | disclosed |